Research Article
[Retracted] Coronary Angiography Safety between Transradial and Transfemoral Access
Table 1
Baseline characteristics of patients (
).
| | Characteristic | Transradial CAG (; %) | Transfemoral CAG (; %) | value |
| | Age (years) | 51 ± 16.4 | 49 ± 14.9 | 0.16 | | Male | 856 (79.6%) | 700 (71.7) | 0.2 | | Female | 220 (20.4%) | 221 (28.3) | 0.23 | | Height (cm) | 166.5 ± 10.8 | 154 ± 8.4 | 0.4 | | Weight (kg) | 63.6 ± 11.2 | 59.2 ± 9.6 | 0.18 | | BMI (kg/m2) | 24.9 ± 2.8 | 23.8 ± 3.6 | 0.4 | | BSA (m2) | 1.66 ± 0.22 | 1.62 ± 0.19 | 0.24 | | Serum creatinine (mg/dL) | 1.2 ± 0.3 | 1.3 ± 0.4 | 0.4 | | CAD risk factors | | | | | Hypertension | 421 (39.1) | 313 (34 ) | 0.32 | | Diabetes mellitus | 358 (33.2) | 268 (29 ) | 0.29 | | Smokers | 323 (30) | 323 (35 ) | 0.31 | | Family history of CAD | 76 (7.1) | 37 (4 ) | 0.43 | | Dyslipidemia | 441 (41) | 335 (36.4 ) | 0.22 | | Clinical diagnosis | | | | | Acute coronary syndrome | 676 (62.8) | 543 (58.9) | 0.12 | | Chronic stable angina | 355 (33) | 240 (26.1) | 0.32 | | Cardiomyopathy | 07 (0.6) | 38 (4.1) | 0.05 | | Chest pain for evaluation | 27 (2.5) | 46 (4.9) | 0.53 | | Previous CABG | 07 (0.6) | 31 (3.3) | 0.04 | | Valvular heart disease | 4 (0.3) | 23 (2.4) | 0.02 | | LVEF (%) | | | | | (a) >45% | 818 (76) | 646 (70.2) | 0.32 | | (b) 35–45% | 120 (11.2) | 154 (16.7) | 0.21 | | (c) <35% | 138 (12.8) | 120 (13.1 ) | 0.4 | | Medications | | | | | Aspirin | 1002 (93.2) | 708 (76.9) | 0.5 | | Clopidogrel | 55 (50.6) | 636 (69.1) | 0.3 | | Prasugrel | 132 (12.3) | 169 (18.4) | 0.11 | | Ticagrelor | 58 (5.8) | 29 (3.2) | 0.33 | | Statin | 981 (91.2) | 722 (78.4) | 0.7 | | Beta-blocker | 785 (72.9) | 620 (67.4) | 0.53 | | ACEI/ARB | 974 (90.5) | 754 (81.9) | 0.19 | | CCB | 230 (21.4) | 268 (29.2) | 0.5 | | Aldosterone antagonist | 132 (12.3) | 84 (9.2) | 0.31 | | Angiographic severity of CAD (obstructive) | 743 (69.1) | 723 (78.6) | 0.42 | | (a) SVD | 350 (47.2) | 420 (58.2) | 0.18 | | (b) DVD | 212 (28.6) | 161 (22.2) | 0.56 | | (c) TVD | 181 (20.4) | 104 (14.3) | 0.67 | | (d) Left main (isolated ± other vessel) | 41 (3.8) | 38 (5.3 ) | 0.3 | | CAD (intermediate 50–70%) | 177 (16.4) | 103 (11.2) | 0.29 | | Non-obs. CAD (recanalised) | 97 (8.9) | 38 (4.2) | 0.44 | | Normal coronaries | 59 (5.4) | 55 (6) | 0.31 |
|
|
Data presented as mean ± standard deviation or number (percentage). BMI = body mass index; BSA = body surface area; CAD = coronary artery disease; DM = diabetes mellitus; LVEF = left ventricular ejection fraction; ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin-receptor blocker; CCB = calcium-channel blocker; SVD = single-vessel disease; DVD = double-vessel disease; TVD = triple-vessel; CABG = coronary artery bypass graft.
|
